Ignite Creation Date:
2025-12-24 @ 11:50 AM
Ignite Modification Date:
2026-02-02 @ 10:28 PM
Study NCT ID:
NCT02378961
Status:
COMPLETED
Last Update Posted:
2020-03-03
First Post:
2015-02-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Non-Genotype 1 HCV Infection
Sponsor:
Gilead Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-02-16
Start Date Type:
ACTUAL
Primary Completion Date:
2015-09-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-01-26
Completion Date Type:
ACTUAL
First Submit Date:
2015-02-27
First Submit QC Date:
None
Study First Post Date:
2015-03-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-08-16
Results First Submit QC Date:
None
Results First Post Date:
2017-09-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2016-06-06
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2020-02-18
Last Update Post Date:
2020-03-03
Last Update Post Date Type:
ACTUAL